MedTrace Logo

CKD-397 Drug-drug Interaction Study (A)

NCT02247518 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2015-08-20

No results posted yet for this study

Summary

The purpose of this study is to investigate to effect of tamsulosin on the pharmacokinetic properties of tadalafil

Conditions

  • Healthy

Interventions

DRUG

Cialis Tab. 5mg

DRUG

Harnal-D Cap. 0.2mg

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Principal Investigators

  • Min Gul Kim, PhD · Chonbuk National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2014-10-31
Completion
2014-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02247518 on ClinicalTrials.gov